Gilbert S. Omenn, Director at Esperion Therapeutics, Inc. (ESPR), bought 5,000 shares at $15.28 ($76K) on 2016-03-01, disclosed to the SEC on 2016-03-02.
Open-market purchase of $76k ESPR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AMST | BUY | 2020-09-29 | $100K | — | Filing → |
| GALT | BUY | 2019-06-03 | $159K | — | Filing → |
| GALT | SELL | 2018-09-11 | $117K | — | Filing → |